XML 69 R61.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Of Financial Instruments - Summary of Warrant Liabilities Measured at Fair Value (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]    
Beginning balance $ 3,899 $ 1,284
Cost of warrants vesting during the period 352 198
Change in fair value included in earnings 5,238 2,417
Exercise of warrants to purchase Legacy Rocket Lab Series C and D preferred stock (6,514)  
Exchange of warrants to purchase Legacy Rocket Lab Series B preferred stock to common stock warrants (2,975)  
Ending balance $ 3,899